Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,214
Total Claims
$797K
Drug Cost
763
Beneficiaries
$1,044
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,961 Nephrology providers
-19%
Cost per patient vs peers
$1,044 vs $1,283 avg
-20%
Brand preference vs peers
7.1% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.2%
Opioid Rate
202
Opioid Claims
$2,673
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 653 claims · $466K
Generic: 8,509 claims · $328K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sucroferric Oxyhydroxide | 26 | $104K |
| Ferric Citrate | 27 | $74K |
| Insulin Aspart | 50 | $57K |
| Dapagliflozin Propanediol | 38 | $32K |
| Apixaban | 40 | $27K |
| Insulin Detemir | 36 | $22K |
| Sitagliptin Phosphate | 29 | $21K |
| Bumetanide | 461 | $21K |
| Allopurinol | 1,253 | $20K |
| Sevelamer Carbonate | 72 | $17K |
| Sevelamer Carbonate | 11 | $13K |
| Terazosin Hcl | 555 | $13K |
| Cinacalcet Hcl | 40 | $12K |
| Sacubitril/Valsartan | 13 | $9,422 |
| Insulin Lispro | 14 | $9,253 |
Prescribing Profile
Patient Profile
73
Avg Age
63%
Female
2.68
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About